The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | D | Dermatologicals | |
| 2 | D06 | Antibiotics and chemotherapeutics for dermatological use | |
| 3 | D06A | Antibiotics for topical use | |
| 4 | D06AX | Other antibiotics for topical use | |
| 5 | D06AX13 | Retapamulin |
| Active Ingredient | Description | |
|---|---|---|
| Retapamulin |
Retapamulin is a semi-synthetic derivative of the compound pleuromutilin, which is isolated through fermentation from Clitopilus passeckerianus. Retapamulin selectively inhibits bacterial protein synthesis by interacting at a unique site on the 50S subunit of the bacterial ribosome that is distinct from the binding sites of other non-pleuromutilin antibacterial agents that interact with the ribosome. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| ALTARGO Ointment | European Medicines Agency (EU) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
